Major grant to advance doctoral training in transformative pharmaceutical technologies

Our Biomaterials and Tissue Engineering Department, together with UCL colleagues*, are celebrating receipt of a major grant to train a new generation of scientists for the pharmaceutical and healthcare sectors.

UCL, the University of Nottingham and the Synthesis & Solid State Pharmaceutical Centre have jointly received £6.1m from the Engineering and Physical Sciences Council in the UK and €3.0m from Science Foundation Ireland. 

The money will fund fifteen PhD studentships in the field of pharmaceutical technologies, under the umbrella of a new EPSRC Centre.

Professor Stephen Porter, Director of UCL Eastman Dental Institute, said: “This is a wonderful opportunity to provide career opportunities for aspiring scientists who may be able to create therapies to prevent or reduce the burden of disease.

“Potentially these postgraduates could transform challenging active ingredients from drug discovery and biotechnology technologies into potent medicines.”

The award was co-funded by 19 industrial partners ranging from small biotechs to global pharmaceutical businesses.  

*The UCL team, who will host six of the fully-funded scholarships, includes Eastman, the School of Pharmacy, UCL Chemistry, and UCL Chemical Engineering. Find out more